Impact of the Cannabinoid System in Alzheimer's Disease

被引：7
作者：
Li, Shuangtao [1 ]
Huang, Yuanbing [2 ]
Yu, Lijun [1 ]
Ji, Xiaoyu [2 ]
Wu, Jie [1 ,3 ]
机构：
[1] Shantou Univ, Brain Funct & Dis Lab, Med Coll, 22 Rd Xinling, Shantou 515041, Guangdong, Peoples R China
[2] Yunfu Peoples Hosp, Dept Neurol, Yunfu 527300, Guangdong, Peoples R China
[3] Shantou Univ, Brain Funct & Dis Lab, Med Coll, Shantou, Peoples R China
来源：
CURRENT NEUROPHARMACOLOGY | 2023年 / 21卷 / 03期
基金：
中国国家自然科学基金;
关键词：
Cannabinoids; CB1; receptor; CB2; endocannabinoid; neurodegenerative diseases; Alzheimer's disease; TRANSGENIC MOUSE MODEL; DRIVEN RAT MODELS; CB2; RECEPTOR; AMYLOID-BETA; MESSENGER-RNA; HUMAN BRAIN; IN-VITRO; ENDOCANNABINOID SYSTEM; FUNCTIONAL EXPRESSION; COGNITIVE IMPAIRMENT;
D O I：
10.2174/1570159X20666220201091006
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Cannabinoids are compounds isolated from cannabis and are also widely present in both nervous and immune systems of animals. In recent years, with in-depth research on cannabinoids, their clinical medicinal value has been evaluated, and many exciting achievements have been continuously accumulating, especially in the field of neurodegenerative disease. Alzheimer's disease is the most common type of neurodegenerative disease that causes dementia and has become a global health problem that seriously impacts human health today. In this review, we discuss the therapeutic potential of cannabinoids for the treatment of Alzheimer's disease. How cannabinoids act on different endocannabinoid receptor subtypes to regulate Alzheimer's disease and the roles of the endocannabinoid system in Alzheimer's disease are outlined, and the underlying mechanisms are discussed. Finally, we summarize the most relevant opportunities of cannabinoid pharmacology related to Alzheimer's disease and discuss the potential usefulness of cannabinoids in the clinical treatment of Alzheimer's disease.
引用
收藏
页码：715 / 726
页数：12
相关论文
共 176 条
  • [1] Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
    Agudo, J.
    Martin, M.
    Roca, C.
    Molas, M.
    Bura, A. S.
    Zimmer, A.
    Bosch, F.
    Maldonado, R.
    [J]. DIABETOLOGIA, 2010, 53 (12) : 2629 - 2640
  • [2] Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease
    Ahmad, Rawaha
    Postnov, Andrey
    Bormans, Guy
    Versijpt, Jan
    Vandenbulcke, Mathieu
    Van Laere, Koen
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2219 - 2227
  • [3] Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
    Ashton, JC
    Friberg, D
    Darlington, CL
    Smith, PF
    [J]. NEUROSCIENCE LETTERS, 2006, 396 (02) : 113 - 116
  • [4] Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer like symptoms in a transgenic animal model
    Aso, Ester
    Andres-Benito, Pol
    Ferrer, Isidre
    [J]. BIOCHEMICAL PHARMACOLOGY, 2018, 157 : 210 - 216
  • [5] Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
    Aso, Ester
    Andres-Benito, Pol
    Carmona, Margarita
    Maldonado, Rafael
    Ferrer, Isidre
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (02) : 489 - 500
  • [6] Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic
    Aso, Ester
    Ferrer, Isidre
    [J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [7] CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
    Aso, Ester
    Juves, Salvador
    Maldonado, Rafael
    Ferrer, Isidro
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (04) : 847 - 858
  • [8] CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
    Aso, Ester
    Palomer, Ernest
    Juves, Salvador
    Maldonado, Rafael
    Munoz, Francisco J.
    Ferrer, Isidro
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (02) : 439 - 459
  • [9] Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier
    Bachmeier, Corbin
    Beaulieu-Abdelahad, David
    Mullan, Michael
    Paris, Daniel
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 56 : 255 - 262
  • [10] Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei
    Baek, Jean-Ha
    Zheng, Yiwen
    Darlington, Cynthia L.
    Smith, Paul F.
    [J]. ACTA OTO-LARYNGOLOGICA, 2008, 128 (09) : 961 - 967
12345678910